1. Home
  2. PTCT vs VNO Comparison

PTCT vs VNO Comparison

Compare PTCT & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$76.82

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Logo Vornado Realty Trust

VNO

Vornado Realty Trust

HOLD

Current Price

$39.72

Market Cap

6.3B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
VNO
Founded
1998
1946
Country
United States
United States
Employees
N/A
3145
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.3B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
PTCT
VNO
Price
$76.82
$39.72
Analyst Decision
Buy
Hold
Analyst Count
17
10
Target Price
$80.65
$33.00
AVG Volume (30 Days)
1.5M
1.6M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
2.52%
EPS Growth
264.48
N/A
EPS
N/A
N/A
Revenue
$264,734,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.70
$5.42
P/E Ratio
N/A
$7.08
Revenue Growth
36.19
N/A
52 Week Low
$43.18
$24.57
52 Week High
$90.87
$43.37

Technical Indicators

Market Signals
Indicator
PTCT
VNO
Relative Strength Index (RSI) 43.24 58.23
Support Level $74.45 $37.92
Resistance Level $79.67 $41.08
Average True Range (ATR) 3.27 1.23
MACD -1.01 -0.20
Stochastic Oscillator 4.47 63.87

Price Performance

Historical Comparison
PTCT
VNO

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About VNO Vornado Realty Trust

Vornado Realty Trust is a fully integrated real estate investment trust with a portfolio of New York City office, retail, and multifamily assets, and the developer of the new Penn District. While concentrated in New York, the trust also owns assets in both Chicago and San Francisco. It generates revenue in the form of property rentals, fees charged for trade shows, parking revenues, management and leasing fees, etc. Vornado operates in the following reportable segments: New York (its key revenue-generating market) and Other.

Share on Social Networks: